|
||||||
| Finally, Weight Loss That Makes Sense! | ||||||
|
Home | How It Works | Clinical Studies | FAQs | Guarantee | Customer Service | Try It Free Today! |
||||||
|
|
|
Clinical Studies What Do You Have To Lose . . . Except Excess Weight! This is a partial list of the many clinical studies performed on the use of Glucomannan for weight control and health aids. For complete list of clinical studies performed on this product, please click here. 1. Diabetes Care 1999 Jun;22(6):913-9 Vuksan V, Jenkins DJ, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, Brighenti F, Josse R, Leiter LA, Bruce-Thompson C.. . . improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. 2. Diabetes Care 2000 Jan;23(1):9-14 Vuksan V, Sievenpiper JL, Owen R, Swilley JA, Spadafora P, Jenkins DJ, Vidgen E, Brighenti F, Josse RG, Leiter LA, Xu Z, Novokmet R.. . . recently received recognition for reducing the risk of developing diabetes and heart disease. 3. Clin Ter 1995 Apr;146(4):269-74 Cairella M, Marchini G.. . . shows that diet plus glucomannan is more effective than the diet alone. 4. Pediatr Padol 1993;28(5):133-6 Vido L, Facchin P, Antonello I, Gobber D, Rigon F. . . .Frequently used for the treatment of paediatric obesity. 5. J Pediatr 2000 Jan;136(I):41-5 Staiano A, Simeone D, Del Guidice E. Miele E, tozzi A, Toraldo C . . . Glucomannan significantly increased stool frequency. Laxative or suppository use was significantly reduced. 6. Minerva Ginecol 1996 Dec;48(12):577-82 Signorelli P, Croce P, Dede A. . . Hunger control induced by glucomannan at the gastric level which prevents an excessive food intake. 7. Ital J Gastroenterol 1991 Sep-Oct;23(7):421-5 Passaretti S, Franzoni M, Comin U, Donzelli R, Rocca F, Colombo E, Ferraa A, Dinelli M, Prada A, Curzio M, et al.. . . Glucomannan was well accepted and devoid of relevant side-effects. 8. Biomed Environ Sci 1995 Mar;8(1):80-7 Peng SS, Zhang MY, Zhang YZ, Wu HZ. . . Glucomannan . . . is likely to delay the occurance of arteriosclerosis and improve the functions of the brain, heart and vascular system. 9. J Nutr 2000 Nov;130(11):2753-9 Gallaher CM, Munion J, Hesslink R Jr, Wise J, Gallaher DD. . . Glucomannan . . . demonstrated to lower cholesterol 10. 260/236.5 424/195,180 127/54 Dec. 1973 Sugiyama; Noboru; Shimahara; Hideo. . . Glucomannan . . . has utility for alleviating constipation and reducing weight. Glucomannan has been used in food for hundreds of years. Changes in blood pressure, blood carbohydrate and cholesterol levels during administration of glucomannon were shown to be reduced after a few weeks. 11. Minerva Med 1992 Mar;83(3):135-9 Chronic use of glucomannan in the dietary treatment of severe obesity Vita PM, Restelli A, Caspani P, Klinger R.. . . In severely obese patients . . . showed that diet plus glucomannan had . . . significant weight loss. Due to the marked ability to satiate patients and the positive metabolic effects, glucomannan diet supplements have been found to be particularly (effective) and well tolerated even in the long-term treatment of severe obesity.
|
|
  |
||
|
For telephone orders, call 800-771-0082 6 AM to 5 PM PST.
These statements have not been evaluated by the Food and Drug Administration. FiberWeigh is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results May Vary. |
||||||
